These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt 2011-000033-36 A phase I/II study of 177Lu-HH1 (BetalutinTM) radioimmunotherapy for treatment of relapsed CD37+ non-Hodgkin lymphoma Studio di Fase I/II di terapia radioimmunologica con 177Lu-DOTA-HH1 (Betalutinℱ... not-yet-due
Reported results 2015-001570-17 A Phase 2 study of the antibody-radionuclide-conjugate 177Lu-DOTA-HH1 (Betalutin?) in patients with CD37-positive relapsed follicular lymphoma Estudio de fase II del conjugado anticuerpo-radionĂșcli... 2015-12-09 due-trials
Ongoing 2017-004506-18 A phase 2 open-label study of Betalutin in combination with rituximab in patients with relapsed/refractory follicular lymphoma (Archer-1) not-yet-due